© Compugen PR Compugen earnings beat, revenue was in line with estimates
Investing.com – Compugen (NASDAQ: ) reported second quarter EPS of $-0.110, better than the analyst estimate of $-0.120. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Compugen’s stock price closed at $1.120. It is up 49.330% in the last 3 months and down -30.950% in the last 12 months.
Compugen saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Compugen’s stock price’s past reactions to earnings here.
According to InvestingPro, Compugen’s Financial Health score is “fair performance”.
Check out Compugen’s , and Compugen’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Read the full article here
